Product
Dupilumab SAR231893
1 clinical trial
1 indication
Indication
Prurigo NodularisClinical trial
Prospective, Non-interventional Observational Study to Characterize Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical RoutineStatus: Recruiting, Estimated PCD: 2025-04-23